CLINICAL_TRIALS ClinicalTrials.gov record update

Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04965597
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:16.054117+00:00
Published At: 2026-03-09T00:00:00+00:00
Record Updated At: 2026-03-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Bone Marrow Failure Syndrome", "Congenital Amegakaryocytic Thrombocytopenia", "Diamond-Blackfan Anemia", "Hereditary Sideroblastic Anemia", "Paroxysmal Nocturnal Hemoglobinuria", "Shwachman-Diamond Syndrome", "Hematologic Neoplasm With Germline GATA2 Mutation", "Hematologic Neoplasm With Germline SAMD9 Mutation", "Hematologic Neoplasm With Germline SAMD9L Mutation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-03-09"
protocolSection.identificationModule.nctId: "NCT04965597"
protocolSection.identificationModule.officialTitle: "Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.